{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:33:03Z","timestamp":1789813983682,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.rdc.2008.08.006","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T03:17:21Z","timestamp":1226287041000},"page":"921-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Mucosa-Associated Lymphoid Tissue Lymphoma in Sj\u00f6gren's Syndrome: Risks, Management, and Prognosis"],"prefix":"10.1016","volume":"34","author":[{"given":"Michael","family":"Voulgarelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haralampos M.","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2008.08.006_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/030097401316909486","article-title":"Rheumatic diseases and malignancy\u2014is there an association?","volume":"30","author":"Leandro","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rdc.2008.08.006_bib2","first-page":"45","article-title":"Development of malignant lymphoma in the course of Sjogren's syndrome","volume":"76","author":"Bunim","year":"1963","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.rdc.2008.08.006_bib3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2008.08.006_bib4","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4049\/jimmunol.130.6.2663","article-title":"High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome","volume":"130","author":"Moutsopoulos","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2008.08.006_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/art.1780290907","article-title":"Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjogren's syndrome","volume":"29","author":"Tzioufas","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.006_bib6","first-page":"2376","article-title":"Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjogren's syndrome","volume":"24","author":"Valesini","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2008.08.006_bib7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJM197811302992204","article-title":"Evidence that the malignant lymphoma of Sjogren's syndrome is a monoclonal B-cell neoplasm","volume":"299","author":"Zulman","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2008.08.006_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00443482","article-title":"Development of malignant lymphoma in myoepithelial sialadenitis (Sjogren's syndrome)","volume":"395","author":"Schmid","year":"1982","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.rdc.2008.08.006_bib9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1084\/jem.174.5.1245","article-title":"High frequency of t(14;18) translocation in salivary gland lymphomas from Sjogren's syndrome patients","volume":"174","author":"Pisa","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2008.08.006_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(98)80040-1","article-title":"Predictors of lymphoma development of primary Sjogren's syndrome","volume":"28","author":"Sutcliffe","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.006_bib11","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2008.08.006_bib12","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sjogren's syndrome: a multicenter, retrospective, clinical study by the European concerted action on Sjogren's syndrome","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.006_bib13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.V90.2.766","article-title":"Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites and are not associated with viruses","volume":"90","author":"Royer","year":"1997","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.rdc.2008.08.006_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/10428199909093729","article-title":"Lymphomas in patients with Sjogren's syndrome: review of the literature and physiopathologic hypothesis","volume":"33","author":"Mariette","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.rdc.2008.08.006_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2004.04993.x","article-title":"Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection","volume":"126","author":"Ambrosetti","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rdc.2008.08.006_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.rdc.2008.08.006_bib17","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2008.08.006_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","article-title":"Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology","volume":"84","author":"M\u00fcller","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rdc.2008.08.006_bib19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ajcp\/96.6.738","article-title":"Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues","volume":"96","author":"Pelstring","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rdc.2008.08.006_bib20","first-page":"1361","article-title":"Expression of lymphocyte homing receptors and\u00a0vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue","volume":"151","author":"Dogan","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2008.08.006_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2559.1987.tb02654.x","article-title":"Malignant lymphoma of mucosa-associated lymphoid tissue","volume":"11","author":"Isaacson","year":"1987","journal-title":"Histopathology"},{"issue":"1 Suppl 1","key":"10.1016\/j.rdc.2008.08.006_bib22","first-page":"S126","article-title":"What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites?","volume":"111","author":"Harris","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rdc.2008.08.006_bib23","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0046-8177(88)80259-4","article-title":"Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis","volume":"19","author":"Hyjek","year":"1988","journal-title":"Hum Pathol"},{"key":"10.1016\/j.rdc.2008.08.006_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00000478-199505000-00004","article-title":"B-cell monoclonality, Epstein Barr virus, and t(14;18) in myoepithelial sialadenitis and low-grade B-cell MALT lymphoma of the parotid gland","volume":"19","author":"Diss","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rdc.2008.08.006_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/1024533021000024058","article-title":"Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis","volume":"7","author":"Rossi","year":"2002","journal-title":"Hematology"},{"key":"10.1016\/j.rdc.2008.08.006_bib26","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood.V88.12.4445.bloodjournal88124445","article-title":"Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma","volume":"88","author":"Du","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2008.08.006_bib27","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1053\/gast.1997.v112.pm9178679","article-title":"Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas","volume":"112","author":"Neumeister","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rdc.2008.08.006_bib28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed","volume":"95","author":"Thieblemont","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2008.08.006_bib29","first-page":"199","article-title":"The spectrum of benign to malignant lymphoproliferation in Sjogren's syndrome","volume":"10","author":"Anderson","year":"1972","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2008.08.006_bib30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.1780390508","article-title":"Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren's syndrome","volume":"39","author":"Tzioufas","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.006_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/ard.45.3.210","article-title":"Urinary monoclonal free light chains in the primary Sjogren's syndrome: an aid to the diagnosis of malignant lymphoma","volume":"45","author":"Walters","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.006_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.006_bib33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.006_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","article-title":"Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome","volume":"44","author":"Ramos-Casals","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2008.08.006_bib35","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.006_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0049-0172(96)80019-9","article-title":"Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome","volume":"25","author":"Anaya","year":"1996","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.006_bib37","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1200\/JCO.1999.17.4.1254","article-title":"Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients","volume":"17","author":"Zinzani","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rdc.2008.08.006_bib38","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"Zucca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2008.08.006_bib39","first-page":"761","article-title":"Malignant lymphoma in primary Sjogren's syndrome","volume":"3","author":"Voulgarelis","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.rdc.2008.08.006_bib40","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1200\/JCO.1995.13.10.2524","article-title":"Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression","volume":"13","author":"Hammel","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rdc.2008.08.006_bib41","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2008.08.006_bib42","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1200\/JCO.2002.05.117","article-title":"Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study","volume":"20","author":"J\u00e4ger","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rdc.2008.08.006_bib43","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/cncr.20237","article-title":"Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma","volume":"100","author":"Zinzani","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.rdc.2008.08.006_bib44","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/art.10434","article-title":"2-chloro-2-deoxyadenosine in the treatment of Sjogren's syndrome-associated B cell lymphoproliferation","volume":"46","author":"Voulgarelis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.006_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<122::AID-PATH486>3.0.CO;2-D","article-title":"Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue","volume":"178","author":"Hussell","year":"1996","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.rdc.2008.08.006_bib46","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study","volume":"52","author":"Pijpe","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.006_bib47","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/ard.2004.030684","article-title":"Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma","volume":"64","author":"Pijpe","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.006_bib48","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","article-title":"Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients","volume":"15","author":"Thieblemont","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rdc.2008.08.006_bib49","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/rheumatology\/keh248","article-title":"Combined therapy with rituximab plus cyclophosphamide\/doxorubicin\/vincristine\/prednisone (CHOP) for Sjogren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas","volume":"43","author":"Voulgarelis","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2008.08.006_bib50","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/ard.2005.046193","article-title":"Long-term remission of Sjogren's syndrome-associated aggressive B-cell non-Hodgkin's lymphomas following administration of combined B-cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)","volume":"65","author":"Voulgarelis","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2008.08.006_bib51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V96.2.410.014k22_410_419","article-title":"The gastric marginal zone B-cell lymphoma of MALT type","volume":"96","author":"Zucca","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2008.08.006_bib52","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-04-2282","article-title":"High relapse rate in patients with MALT lymphoma warrants lifelong follow-up","volume":"11","author":"Raderer","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.rdc.2008.08.006_bib53","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/0016-5085(92)91723-H","article-title":"Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis","volume":"102","author":"Radaszkiewicz","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rdc.2008.08.006_bib54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/oxfordjournals.annonc.a059184","article-title":"Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients","volume":"6","author":"Montalb\u00e1n","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rdc.2008.08.006_bib55","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2005.05.660","article-title":"Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy","volume":"23","author":"L\u00e9vy","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9249","key":"10.1016\/j.rdc.2008.08.006_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","article-title":"Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy","volume":"357","author":"Liu","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2008.08.006_bib57","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","article-title":"Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy","volume":"23","author":"Martinelli","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rdc.2008.08.006_bib58","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1158\/1078-0432.CCR-0873-03","article-title":"Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sjogren's syndrome","volume":"10","author":"Streubel","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.rdc.2008.08.006_bib59","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X08000811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X08000811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:07:20Z","timestamp":1760180840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X08000811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0889857X08000811"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2008.08.006","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosa-Associated Lymphoid Tissue Lymphoma in Sj\u00f6gren's Syndrome: Risks, Management, and Prognosis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2008.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}